This decrease in oxidative stress and neuroinflammation with Melatonin treatment may be due to increase in Nrf2/HO1 associated antioxidant enzymes, and inhibition of NF-κB expression also showed in Streptozotocin induced diabetic neuropathy and other models [57, 58]. Here, NFE2L2 is linked to diabetic neuropathy.